Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP2 | O95551 | 1/20 | 0.50 |
| ▸ | NSD2 | O96028 | 1/20 | 0.50 |
| ▸ | ABL1 | P00519 | 1/20 | 0.50 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.50 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | TOP1 | P11387 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.45 |
| ▸ | TGFBR1 | P36897 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30117887 | 0.94 | PTGS2 (0.51) | TDP2NSD2ABL1PLCG1CES1 | |
| SCHEMBL15638432 | 0.94 | PTGS2 (0.51) | TDP2NSD2ABL1PLCG1CES1 | |
| SCHEMBL29864544 | 0.88 | PTGS2 (0.59) | TOP1CYP1A2CYP2C19MAPK14PTGS2 | |
| SCHEMBL15637997 | 0.87 | GABRG2 (0.46) | TOP1CYP1A2CYP2C19MAPK14PTGS2 | |
| SCHEMBL18448246 | 0.85 | ADORA1 (0.46) | ABL1TOP1CYP1A2CYP2C19MAPK14 | |
| SCHEMBL15639245 | 0.84 | TOP1 (0.47) | TOP1CYP1A2CYP2C19MAPK14PTGS2 | |
| SCHEMBL15638779 | 0.84 | CDC7 (0.47) | TOP1CYP1A2CYP2C19PTGS2PTGS1 | |
| SCHEMBL3881160 | 0.83 | CYP11B2 (0.50) | TOP1KMT2AMAPK14PTGS2PTGS1 | |
| SCHEMBL2757253 | 0.81 | MKNK1 (0.59) | TOP1THRBMAPK14PTGS2PTGS1 | |
| SCHEMBL15638336 | 0.80 | NPC1 (0.47) | TOP1MAPK14PTGS2PTGS1TGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1554361-B1 | METALLIC COMPLEXES COVALENTLY BOUND TO CONJUGATED POLYMERS AND ELECTRONIC DEVICES CONTAINING SUCH COMPOSITIONS | DU PONT (US) | 2010-03-17 | — | — | EP | disclosed |
| US-7575816-B2 | Luminescent lanthanide complexes with imine ligands and devices made with such complexes | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-08-18 | — | — | US | disclosed |
| US-7090929-B2 | Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2006-08-15 | — | — | US | disclosed |
| US-20050233233-A1 | Luminescent lanthanide complexes with imine ligands and devices made with such complexes | RADU NORA S | 2005-10-20 | — | — | US | disclosed |
| US-20050233232-A1 | Luminescent lanthanide complexes with imine ligands and devices made with such complexes | LG CHEM, LTD. (KR) | 2005-10-20 | — | — | US | disclosed |
| US-6924047-B2 | Luminescent lanthanide complexes with imine ligands and devices made with such complexes | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2005-08-02 | — | — | US | disclosed |
| EP-1554361-A1 | METALLIC COMPLEXES COVALENTLY BOUND TO CONJUGATED POLYMERS AND ELECTRONIC DEVICES CONTAINING SUCH COMPOSITIONS | E. I. du Pont de Nemours and Company (US) | 2005-07-20 | — | — | EP | disclosed |
| US-20040072018-A1 | Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions | LG CHEM, LTD. (KR) | 2004-04-15 | — | — | US | disclosed |
| WO-2004015025-A1 | METALLIC COMPLEXES COVALENTLY BOUND TO CONJUGATED POLYMERS AND ELECTRONIC DEVICES CONTAINING SUCH COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050233233-A1 | Luminescent lanthanide complexes with imine ligands and devices made with such complexes | SSB, LARP7, LIG3 | TDP2 2514/4885NSD2 2989/4885ABL1 764/4885 |
| US-20050233232-A1 | Luminescent lanthanide complexes with imine ligands and devices made with such complexes | SSB, LARP7, LIG3 | TDP2 2514/4885NSD2 2989/4885ABL1 764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.